Abeona Therapeutics (ABEO) ABO-101 Gene Therapy Gains Orphan Drug Status in EU – StreetInsider.com
|
Abeona Therapeutics (ABEO) ABO-101 Gene Therapy Gains Orphan Drug Status in EU
StreetInsider.com Abeona Therapeutics Inc. (Nasdaq: ABEO) announced today that the European Medicines Agency (EMA) Committee for Orphan Medicinal Products has granted Orphan Drug Designation (EMA/OD/226/16) for Abeona's gene therapy program ABO-101 for … |
